<DOC>
	<DOCNO>NCT01461720</DOCNO>
	<brief_summary>This study aim determine efficacy intravenous transplantation autologous bone marrow-derived mesenchymal stem cell patient acute middle cerebral artery infarct .</brief_summary>
	<brief_title>Intravenous Autologous Mesenchymal Stem Cells Transplantation Treat Middle Cerebral Artery Infarct</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<criteria>Experiences stroke onset within 2 week 2 month NIHSS score &gt; 1035 Never receive failed thrombolysis Evidence unilateral middle cerebral artery infarct brain MRI Medically unfit ( eg . unstable haemodynamically despite treatment , worsen conscious level serious medical comorbidity ) Evidence tumor spaceoccupying lesion brain MRI Evidence hemorrhagic stroke brain CT MRI Experiences transient ischemic attack lacunar infarct Has acute chronic infection Hepatitis B , Hepatitis C HIV Is diagnose concurrent malignancy primary hematological disorder Renal impairment indicate serum creatinine great 200 umol/l creatinine clearance le 30 ml/min Liver impairment indicate serum aspartate transaminase serum alanine transaminase great 4 time upper limit normal range Any contraindication stem cell transplantation bone marrow biopsy Any comorbidity compromise ability obtain adequate stem cell ( eg . chronic debilitating disease , frail patient patient know osteoporosis ) Any contraindication brain MRI ( eg . metal implant , pacemaker , joint implant ocular implant )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Bone marrow</keyword>
	<keyword>Autologous</keyword>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>Unilateral middle cerebral artery infarct</keyword>
</DOC>